GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Receivables Turnover

Shenzhen Weiguang Biological Products Co (SZSE:002880) Receivables Turnover : 3.54 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Shenzhen Weiguang Biological Products Co's Revenue for the three months ended in Mar. 2024 was ¥226 Mil. Shenzhen Weiguang Biological Products Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥64 Mil. Hence, Shenzhen Weiguang Biological Products Co's Receivables Turnover for the three months ended in Mar. 2024 was 3.54.


Shenzhen Weiguang Biological Products Co Receivables Turnover Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co Receivables Turnover Chart

Shenzhen Weiguang Biological Products Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.05 7.51 7.70 5.78 13.25

Shenzhen Weiguang Biological Products Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.21 3.78 5.03 5.21 3.54

Competitive Comparison of Shenzhen Weiguang Biological Products Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Weiguang Biological Products Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhen Weiguang Biological Products Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Weiguang Biological Products Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Shenzhen Weiguang Biological Products Co's Receivables Turnover falls into.



Shenzhen Weiguang Biological Products Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Shenzhen Weiguang Biological Products Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=1048.503 / ((102.844 + 55.403) / 2 )
=1048.503 / 79.1235
=13.25

Shenzhen Weiguang Biological Products Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

Receivables Turnover (Q: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2024 ) / ((Accounts Receivable (Q: Dec. 2023 ) + Accounts Receivable (Q: Mar. 2024 )) / count )
=226.302 / ((55.403 + 72.424) / 2 )
=226.302 / 63.9135
=3.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhen Weiguang Biological Products Co  (SZSE:002880) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Shenzhen Weiguang Biological Products Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Shenzhen Weiguang Biological Products Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Traded in Other Exchanges
N/A
Address
Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107
Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines